Triple GH Stack
88
synergie
3
957
advanced
May 17, 2026
Aperçu
The Triple GH Stack amplifies the classic CJC-1295 + Ipamorelin protocol with Sermorelin, adding a third GHRH-pathway stimulant to maximize pituitary priming and increase the duration of GH stimulation beyond what CJC-1295 alone provides. Sermorelin is the shortest functional GHRH analog — a 29-amino acid truncated version of native GHRH. Where CJC-1295 provides a longer-acting GHRH signal, Sermorelin provides a more physiologically rapid, native-pattern pulse. Together they create a layered stimulation pattern: Sermorelin fires first with a sharp, natural signal, while CJC-1295 extends and sustains the pituitary response over a longer window. Ipamorelin continues to provide ghrelin-pathway amplification, ensuring the pituitary primed by CJC-1295 and Sermorelin releases its maximum GH payload with each pulse. The result is higher peak GH secretion and more frequent physiological pulses throughout the day and night. The 5-days-on/2-days-off cycling on Sermorelin (typically weekdays, off weekends) preserves receptor sensitivity on the GHRH pathway and prevents the tachyphylaxis that can occur with continuous stimulation. This stack is used by advanced practitioners seeking maximum GH axis stimulation without exogenous HGH. Blood work monitoring (IGF-1, fasting glucose) every 6–8 weeks is essential.
Protocole de dose
300 mcg
par dose
300 mcg
par dose
500 mcg
par dose
Objectifs & Preuves
Avertissements
- Multi-GHRH stacking increases risk of pituitary receptor downregulation. Cycle carefully and monitor IGF-1 levels.
Comments
Sign in to join the discussion
Avertissement : Ce stack est soumis par la communauté et est destiné à des fins de recherche uniquement. Peptide Contacts ne vérifie pas la sécurité ou l'efficacité des stacks soumis. Consultez toujours un professionnel qualifié de la santé avant d'utiliser tout protocole de péptides.